Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 215.50 -3.55 (1.62%)
Previous Close $219.05    52 Week High $333.65 
Open $219.05    52 Week Low $223.02 
Day High $220.17    P/E 27.59 
Day Low $215.26    EPS $7.81 
Volume 2,635,886       

(NASDAQ: IONS) Delayed: 44.44 -2.31 (4.94%)
Previous Close $46.75    52 Week High $62.68 
Open $46.75    52 Week Low $19.59 
Day High $46.75    P/E N/A 
Day Low $44.27    EPS $0.00 
Volume 7,369,252